Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven J Buskirk

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
International Journal of Radiation Oncology, Biology, Physics|May 26, 2009
Evaluation of ki-67 staining levels as an independent biomarker of biochemical recurrence after salvage radiation therapy for prostate cancerAlexander S Parker, Michael G Heckman, Kevin J Wu, et al.
Urology|January 1, 2013
Effect of leuprolide on serum amyloid-β peptide levels and memory in patients with prostate cancer with biochemical recurrenceWinston W Tan, Michael G Heckman, Prakash Vishnu, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|November 30, 2017
Treatment of a glioblastoma multiforme dural metastasis with stereotactic radiosurgery: A case report and select review of the literatureLauren L Hintenlang, Daniel H Miller, Tasneem Kaleem, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|October 9, 2013
Image-guided intensity-modulated radiotherapy for prostate cancer: Dose constraints for the anterior rectal wall to minimize rectal toxicityJennifer L Peterson, Steven J Buskirk, Michael G Heckman, et al.
Journal of Radiation Oncology|September 28, 2013
Lack of Association between COX-2 Staining Level and Biochemical Recurrence Following Salvage Radiation Therapy for Recurrent Prostate CancerMichael G Heckman, Katherine S Tzou, Alexander S Parker, et al.
Mayo Clinic Proceedings|April 6, 2020
Addressing Sexual Harassment in the #MeToo Era: An Institutional ApproachCharanjit S Rihal, Nichelle A Baker, Brian E Bunkers, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 2020
Impact of Patient Stage and Disease Characteristics on the proposed Radiation Oncology Alternative Payment Model (RO-APM)Mark R Waddle, William C Stross, Laura A Vallow, et al.
Brachytherapy|August 20, 2013
Complications after 90Y microsphere radioembolization for unresectable hepatic tumors: An evaluation of 112 patientsJennifer L Peterson, Laura A Vallow, Douglas W Johnson, et al.
The Journal of Urology|August 8, 2006
Salvage radiotherapy for isolated prostate specific antigen increase after radical prostatectomy: evaluation of prognostic factors and creation of a prognostic scoring systemSteven J Buskirk, Thomas M Pisansky, Steven E Schild, et al.
BJU International|July 21, 2015
Proposed prognostic scoring system evaluating risk factors for biochemical recurrence of prostate cancer after salvage radiation therapyRichard J Lee, Katherine S Tzou, Michael G Heckman, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
International Journal of Radiation Oncology, Biology, Physics|May 26, 2009
Evaluation of ki-67 staining levels as an independent biomarker of biochemical recurrence after salvage radiation therapy for prostate cancerAlexander S Parker, Michael G Heckman, Kevin J Wu, et al.
Urology|January 1, 2013
Effect of leuprolide on serum amyloid-β peptide levels and memory in patients with prostate cancer with biochemical recurrenceWinston W Tan, Michael G Heckman, Prakash Vishnu, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|November 30, 2017
Treatment of a glioblastoma multiforme dural metastasis with stereotactic radiosurgery: A case report and select review of the literatureLauren L Hintenlang, Daniel H Miller, Tasneem Kaleem, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|October 9, 2013
Image-guided intensity-modulated radiotherapy for prostate cancer: Dose constraints for the anterior rectal wall to minimize rectal toxicityJennifer L Peterson, Steven J Buskirk, Michael G Heckman, et al.
Journal of Radiation Oncology|September 28, 2013
Lack of Association between COX-2 Staining Level and Biochemical Recurrence Following Salvage Radiation Therapy for Recurrent Prostate CancerMichael G Heckman, Katherine S Tzou, Alexander S Parker, et al.
Mayo Clinic Proceedings|April 6, 2020
Addressing Sexual Harassment in the #MeToo Era: An Institutional ApproachCharanjit S Rihal, Nichelle A Baker, Brian E Bunkers, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 2020
Impact of Patient Stage and Disease Characteristics on the proposed Radiation Oncology Alternative Payment Model (RO-APM)Mark R Waddle, William C Stross, Laura A Vallow, et al.
Brachytherapy|August 20, 2013
Complications after 90Y microsphere radioembolization for unresectable hepatic tumors: An evaluation of 112 patientsJennifer L Peterson, Laura A Vallow, Douglas W Johnson, et al.
The Journal of Urology|August 8, 2006
Salvage radiotherapy for isolated prostate specific antigen increase after radical prostatectomy: evaluation of prognostic factors and creation of a prognostic scoring systemSteven J Buskirk, Thomas M Pisansky, Steven E Schild, et al.
BJU International|July 21, 2015
Proposed prognostic scoring system evaluating risk factors for biochemical recurrence of prostate cancer after salvage radiation therapyRichard J Lee, Katherine S Tzou, Michael G Heckman, et al.
Pageof 5